Clicks Group Ltd (CLCGY) Fair Value & Analysis

Healthcare · US · Market cap $3.3B · ISIN US18682W2052

What is Clicks Group Ltd really worth?

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

What matters now

• The rarer combination: high quality (74/100) AND below fair value. That earns a closer look rather than a quick verdict.
• The price is below even our cautious bear case ($26.27). The market is more pessimistic than our downside scenario.

Price vs Fair Value (5 years)

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 29, 2026.

How to read this chart

60‑month range $22.01 – $44.57 · fair‑value band $26.27 – $43.78 · the $25.63 price screens below the $35.03 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Aug 29, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Clicks Group Ltd (CLCGY) currently trades at $25.63, while our model-based Fair Value estimate is $35.03, implying the stock looks roughly 26.8% undervalued today. The Quality Score stands at 74/100 (solid quality), in the Healthcare sector. Bull case: the Earnings-Based group reads highest at a median of $246.68 per share, and 26 of the 26 models we run sit above the $25.63 price. Bear case: the Asset-Based group reads lowest at $39.17, and 0 of the 26 models stay below the price. Evidence for this calculation is medium.

Over the trailing twelve months, Clicks Group Ltd generated revenue of $49.5B at a net margin of 6.7%. Revenue grew 7.4% year over year. It earns a return on equity of 53.3%. Net debt stands at $3.5B. Fundamentals as of Aug 29, 2026

Our scenario range runs from $26.27 (bear case) to $43.78 (bull case); at $25.63, the current price sits below that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 41% below its 52-week high, currently below its 200-day average. For context, the median of 10 Healthcare peers we cover trades at −21% fair-value upside, at 37%, CLCGY screens cheaper than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted, family-balanced blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small. Every input is real reported data, nothing guessed.

Widest divergence: DCF Models ($674.82) versus Asset-Based ($39.17). Highest evidence: FCF DCF (79).

Key figures & financial health

Quality Score breakdown

About the company

Clicks Group Limited, together with its subsidiaries, operates as a health, wellness, and beauty retailer in South Africa and internationally. The company operates through two segments, Retail and Distribution.

Full company description

Clicks Group Limited, together with its subsidiaries, operates as a health, wellness, and beauty retailer in South Africa and internationally. The company operates through two segments, Retail and Distribution. It provides retail, including Clicks, a specialist health, beauty and homeware retailer; Sorbet, a franchise of hair and beauty salons; 180 Degrees Marketing, a software development company; and The Body shop, which specializes in naturally inspired luxury toiletries, cosmetics, gifting and grooming, with stores. The company also offers various ranges of mother-and-baby products, including baby hardware, accessories, health, food, diaper and wipes, and baby toiletries under the Clicks Baby brand; and diabetic clinic, travel clinic, and wound management practice under the M-KEM brand. In addition, the company is involved in the wholesale and supply of pharmaceutical products to retail pharmacies, private hospitals, dispensing doctors, and retail health stores under the UPD brand. The company was formerly known as New Clicks Holdings Limited and changed its name to Clicks Group Limited in June 2009. Clicks Group Limited was founded in 1968 and is headquartered in Cape Town, South Africa.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

Clicks Group Ltd reported revenue of 50.0B ZAR in FY2025 versus 37.3B ZAR in FY2021, a compound +7.6%/yr. Reported net income was 3.2B ZAR in FY2025, compounding +14.5%/yr from FY2021.

Watch CLCGY: get an alert when its fair value changes →

Peer Group

Pharmaceutical Retailers · 57 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Valuation Multiples vs Pharmaceutical Retailers median · lower = cheaper

Strength profile in five axes (Snowflake)

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

Similar stocks

10 more Pharmaceutical Retailers stocks, each showing price versus our Fair Value estimate (as of Aug 29, 2026).

Explore undervalued stocks

More undervalued Healthcare stocks →

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

Discover tools

Frequently asked questions